Congenital muscular dystrophy due to phosphatidylcholine biosynthesis defect (Q103672): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed label, description and/or aliases in pt-br, en |
Changed an Item |
||
| Property / Canonical URI | |||
| Property / Canonical URI: https://id.who.int/icd/entity/515608669 / rank | |||
Normal rank | |||
Revision as of 09:25, 17 August 2026
Congenital myopathy characterised clinically by early onset muscle weakness and mental retardation. The hallmark of the disease is the presence in the muscle biopsy specimen of greatly enlarged mitochondria displaced to the periphery of the fibres. It is caused by mutations in the gene encoding choline kinase beta, the enzyme that catalyzes the first step in the de novo biosynthesis of phosphatidyl choline and phosphatidylethanolamine.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_515608669 |
||
| English | Congenital muscular dystrophy due to phosphatidylcholine biosynthesis defect |
Congenital myopathy characterised clinically by early onset muscle weakness and mental retardation. The hallmark of the disease is the presence in the muscle biopsy specimen of greatly enlarged mitochondria displaced to the periphery of the fibres. It is caused by mutations in the gene encoding choline kinase beta, the enzyme that catalyzes the first step in the de novo biosynthesis of phosphatidyl choline and phosphatidylethanolamine. |
